Methadone is one of the most effective treatments available for opioid use disorder. It reduces opioid overdose deaths by 59% over 12 months compared to no medication treatment, according to research supported by the National Institutes of Health. It is considered the gold standard in medication-assisted treatment and has decades of evidence behind it.
How Methadone Works in the Body
Methadone binds to the same receptors in the brain that heroin and prescription opioids target, but it does so in a slower, more controlled way. It binds to these receptors with greater selectivity than morphine or most other commonly used opioids. This steady binding does two things at once: it prevents withdrawal symptoms and suppresses cravings without producing the intense high associated with other opioids.
What makes methadone particularly useful for long-term treatment is that tolerance does not develop to its core therapeutic effects. Once a person is stabilized on a daily dose, the medication continues to prevent withdrawal symptoms and suppress cravings over time. Meanwhile, the person develops a high level of cross-tolerance to other opioids, meaning that using heroin or similar drugs on top of methadone produces a significantly blunted effect. This combination of sustained craving suppression and reduced reward from other opioids is what gives methadone its effectiveness.
The Effective Dose Range
Methadone works best at adequate doses, and underdosing is one of the most common reasons treatment falls short. Clinical guidelines indicate that doses above 60 mg per day are most effective. Patients receiving doses in this range are less likely to use or inject drugs compared to those on lower doses. The typical maintenance dose falls between 60 and 120 mg daily, though some people need more or less depending on their history of opioid use. The right dose prevents withdrawal without producing euphoria.
Recent federal regulations have updated the initial dosing rules, allowing up to 50 mg on the first day of treatment, with the option for higher doses when clinically appropriate. This change reflects growing recognition that getting people to an effective dose quickly improves outcomes.
Overdose and Mortality Reduction
The most striking evidence for methadone’s effectiveness is its impact on survival. People receiving methadone after an opioid overdose were 59% less likely to die from a subsequent overdose over the following year compared to those not receiving any medication treatment. For comparison, buprenorphine (the other widely used medication for opioid use disorder) reduced overdose deaths by 38% over the same period. Both medications save lives, but methadone shows a larger mortality reduction.
How Methadone Compares to Other Medications
Three medications are approved for opioid use disorder: methadone, buprenorphine, and naltrexone. Each works differently, and they are not interchangeable for every patient.
Methadone is widely regarded as the most effective option for treatment retention and harm reduction. Buprenorphine is considered the second most effective, with some evidence suggesting it may produce slightly lower rates of illicit opioid use when measured by urine testing. However, buprenorphine offers greater flexibility since it can be prescribed from a regular doctor’s office rather than requiring daily clinic visits.
Naltrexone takes a completely different approach. Instead of activating opioid receptors, it blocks them. The oral form has poor adherence and is largely considered ineffective for most people. The injectable extended-release version performs better, reducing relapse and improving quality of life, but it requires 7 to 14 days of complete opioid abstinence before starting. That abstinence period is a significant barrier, as many people relapse before they can begin. Methadone, by contrast, can be started at any stage of withdrawal.
Benefits Beyond Addiction
Methadone’s effectiveness extends well beyond reducing drug use. Because it decreases injection drug use, it serves as both primary and secondary HIV prevention. Research has documented dramatic reductions in new HIV infections among people who enter methadone treatment compared to those who continue injecting heroin. Countries that have implemented large-scale methadone programs, including China, have reported measurable drops in injection-related HIV transmission.
Methadone treatment also improves access to and retention on HIV medications and other medical therapies. People who are stabilized on methadone are more likely to attend medical appointments, maintain consistent treatment for other health conditions, and experience lower overall medical complications. One study found that rapid access to methadone with limited counseling services produced a 50% reduction in opioid-positive urine tests within just 30 days.
The picture for employment is more complex. Among people who were already employed when entering treatment, those on medication for opioid use disorder were about 11% less likely to lose their jobs compared to those not receiving medication. However, for people who were unemployed at admission, medication alone did not improve the odds of finding work during treatment. This suggests methadone is effective at helping people maintain stability but may need to be paired with vocational support for those starting from a more difficult position.
Common Side Effects
Methadone does come with side effects, particularly early in treatment. The most frequently reported include constipation, heavy sweating, nausea or vomiting, sexual problems, itchy skin, restlessness, and slowed breathing. Many of these diminish over time as the body adjusts, though constipation and sweating often persist with long-term use. For most people, these side effects are manageable and significantly outweighed by the benefits of treatment.
How Treatment Is Structured
Unlike buprenorphine, methadone for opioid use disorder can only be dispensed through specialized clinics called opioid treatment programs. This means daily visits to receive a supervised dose, especially in the early stages of treatment. For many people, the requirement to show up at a clinic every morning is the biggest practical barrier.
Recent federal rule changes have loosened some of these restrictions. All patients can now receive take-home doses for days the clinic is closed, including weekends and holidays, regardless of how long they have been in treatment. Within the first 14 days, clinicians can provide up to a 7-day take-home supply if they determine the benefits outweigh the risks. Decisions about take-home doses are based on factors like the absence of active substance use, regular attendance, safe storage at home, and no history of diverting medication.
These changes represent a significant shift toward making methadone treatment more accessible and less disruptive to daily life, which matters because treatment retention is closely tied to how practical the program is for each individual.